Sex hormone levels in drug-naive, first-episode patients with psychosis

被引:9
|
作者
Petrikis, Petros [1 ]
Tigas, Stelios [2 ]
Tzallas, Alexandros T. [3 ]
Karampas, Andreas [1 ]
Papadopoulos, Ioannis [1 ]
Skapinakis, Petros [1 ]
机构
[1] Univ Ioannina, Sch Med, Dept Psychiat, POB 1186, GR-45110 Ioannina, Greece
[2] Univ Ioannina, Sch Med, Dept Endocrinol, Ioannina, Greece
[3] Univ Ioannina, Sch Informat & Telecommun, Dept Informat & Telecommun, Arta, Greece
关键词
Drug-naive; first-episode patients with psychosis; sex hormones; NEGATIVE SYMPTOMS; TESTOSTERONE; SCHIZOPHRENIA; SEVERITY; ESTROGEN;
D O I
10.1080/13651501.2019.1699117
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Aim: Sex differences have long been reported in schizophrenia leading to the hypothesis that sex hormones may be implicated in the pathophysiology of the disorder. We assessed gonadal hormones during the fasted state in drug-naive patients with psychosis. Method: Fasting serum concentrations of follicular-stimulating hormone (FSH) and luteinizing hormone (LH), testosterone, free-testosterone, Sex Hormone Binding Globulin (SHBG) and oestradiol (E-2) were compared between a group of 55 newly diagnosed, drug-naive, first-episode men with psychosis and a group of 55 healthy controls, matched for age, smoking status and BMI. Testosterone, free-testosterone and SHBG were compared between a group of 32 drug-naive, first-episode females with psychosis and a group of 32 healthy controls matched for age, smoking status and BMI. Results: Testosterone and free-testosterone levels were significantly lower in the patients' group and SHBG levels significantly higher in the patients' group compared to those in healthy controls. The two female groups had similar values in the hormones which were measured. Conclusion: Our findings provide evidence of lower testosterone and free-testosterone levels and increased SHBG levels in drug-naive, first-episode males with psychosis.
引用
下载
收藏
页码:20 / 24
页数:5
相关论文
共 50 条
  • [21] Metabolic syndrome in drug-naive first-episode psychosis treated with atypical antipsychotics
    Sahoo, Saddichha
    Ameen, Shahul
    Akhtar, Sayeed
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2007, 41 (07): : 629 - 629
  • [22] Are metabolic indices different between drug-naive first-episode psychosis patients and healthy controls?
    Sengupta, Sarojini
    Parrilla-Escobar, Maria A.
    Klink, Ruby
    Fathalli, Ferid
    Ng, Ying Kin
    Stip, Emmanuel
    Baptista, Trino
    Malla, Ashok
    Joober, Ridha
    SCHIZOPHRENIA RESEARCH, 2008, 102 (1-3) : 329 - 336
  • [23] Cognitive Impairments in Drug-Naive Patients With First-Episode Negative Symptom-Dominant Psychosis
    Zhang, TianHong
    Wei, YanYan
    Tang, XiaoChen
    Cui, HuiRu
    Hu, YeGang
    Xu, LiHua
    Liu, HaiChun
    Wang, ZiXuan
    Chen, Tao
    Hu, Qiang
    Li, ChunBo
    Wang, JiJun
    JAMA NETWORK OPEN, 2024, 7 (06) : E2415110
  • [24] Increased serum prolactin levels in drug-naive first-episode male patients with schizophrenia
    Albayrak, Yakup
    Beyazyuz, Murat
    Beyazyuz, Elmas
    Kuloglu, Murat
    NORDIC JOURNAL OF PSYCHIATRY, 2014, 68 (05) : 341 - 346
  • [25] Effect of risperidone on serum homocysteine levels in first-episode, drug-naive patients with schizophrenia
    Fan, Ning
    Tan, Yunlong
    Yang, Fude
    Tian, Li
    Chen, Song
    Li, Jia
    Wang, Zhiren
    Zhang, Xiangyang
    NEUROSCIENCE LETTERS, 2017, 650 : 168 - 173
  • [26] Prolactin levels in drug-naive first episode nonaffective psychosis patients compared with healthy controls. Sex differences
    Del Cacho, N.
    Butjosa, A.
    Vila-Badia, R.
    Cuadras, D.
    Kaplan, M.
    Rubio-Abadal, E.
    Pardo, M.
    Munoz-Samons, D.
    Cuevas-Esteban, J.
    Saenz-Navarrete, G.
    Ahicart, A.
    Alvarez, M.
    Arranz, B.
    Barneda, V
    Bogas, J. L.
    Bonilla, R.
    Butjosa, A.
    Casali, T.
    Colomer, B.
    Coromina, M.
    Cunill, R.
    Cunat, O.
    del Hoyo, B.
    Delisau, Y.
    Dolz, M.
    Ferrer, I
    Foix, A.
    Grases, N.
    Iglesias-Gonzalez, M.
    Ledesma-Ipaguirre, G.
    Lopez-Ortiz, C.
    Membrive, P.
    Minambres, A.
    Munoz-Samons, D.
    Ochoa, S.
    Pastrana, N.
    Rodriguez, M. J.
    Pelaez, T.
    Salto, C.
    Sibelo, S.
    Nunez, C.
    Nunez, M.
    Pardo, M.
    Redin, J.
    Riera-Lopez de Aguileta, I
    Romans, C.
    Rubio-Abadal, E.
    Santos, A.
    Sole, L.
    Soler, A.
    PSYCHIATRY RESEARCH, 2019, 276 : 218 - 222
  • [27] The need for drug-naive research in first-episode psychosis: a response to Moncrieff & Leo (2010)
    Nelson, B.
    Yung, A. R.
    McGorry, P. D.
    Spiliotacopoulos, D.
    Francey, S. M.
    PSYCHOLOGICAL MEDICINE, 2011, 41 (05) : 1117 - 1118
  • [28] Comparison of baseline metabolic variables between drug-naive first-episode psychosis patients and healthy controls
    Parrilla, M. A.
    Sengupta, S. M.
    Kin, N. M.
    Klink, R.
    Stip, E.
    Baptista, T.
    Malla, A.
    Joober, R.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 244 - 244
  • [29] PROLACTIN LEVELS IN FIRST EPISODE DRUG-NAIVE WOMEN WITH NON AFFECTIVE PSYCHOSIS
    Garcia-Rizo, Clemente
    Fernandez-Egea, Emilio
    Bernardo, Miguel
    Kirkpatrick, Brian
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 253 - 253
  • [30] Microglial activation in first-episode and drug-naive schizophrenia
    Iwata, Y.
    Suzuki, K.
    Mori, N.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 62 - 62